Multinationals Step Up Clinical Trials In South Korea

SEOUL - More and more multinational companies are coming to South Korea to conduct clinical trials, taking advantage of the country's well-trained workforce, well-established infrastructure, lower cost compared with other advanced countries and competitive R&D capability